Fundraising FoxSenisca
3 known investors
Find your way into Senisca
Sign up to see every warm intro you have to Senisca
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Senisca team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease. Its work centers on modulating RNA biology to address the molecular mechanisms driving cellular ageing.
Founders & leadership
Investors · 3
How we know: funding news · Not right? Tell us
How we know: Lifespan Vision Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- SENISCA LTD
- Company number
- 12948837
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Oct 2020
- Registered office
- Innovation Centre University Of Exeter, Rennes Drive, Exeter, Devon, EX4 4RN
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 12 Oct 2025 · next due 26 Oct 2026
Current officers · 7
- Edward Scott Beattie — director, appointed 1 Jul 2024
- Sarah Louise Cole — director, appointed 1 Jan 2024
- Timothy Peter Warren Edwards — director, appointed 1 Aug 2024
- Lorna Harries — director, appointed 13 Oct 2020
- Richard Ian Haycock — director, appointed 1 Jan 2024
- Benjamin Lee — director, appointed 13 Oct 2020
- Allan Benjamin Elias Weiner — director, appointed 1 Jan 2024
Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Senisca do?
- SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease. Its work centers on modulating RNA biology to address the molecular mechanisms driving cellular ageing.
- Who founded Senisca?
- Senisca was founded by Lorna Harries.
- Who are Senisca's investors?
- Senisca's investors include APEX Ventures, Lifespan Vision Ventures, R42 Group.